Choosing First-Line Treatment of Metastatic Colorectal Cancer Based on Biomarker Ras Status- A Budget Impact Analysis From Brazilian Health Insurance System Perspective
Abstract
Authors
PV Souza AC Simões FE Zanini
PV Souza AC Simões FE Zanini
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now